General
publicado em 04/11/2013 às 12h39:00
   Dê o seu voto:

Advances in the treatment of hepatitis C in Brazil will be presented in the U.S.

Brazil is included in the studies and there are patients treated at the Health System receiving medications

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Sebastian Kaulitzki/Foto Stock
Physical activity, healthy diet and the use of some medications can help reduce the level of fat in the liver
  « Previous
next »  
Physical activity, healthy diet and the use of some medications can help reduce the level of fat in the liver

The results of treatment of patients suffering from hepatitis C with protease inhibitors is one of the issues that medical experts discuss the disease in 64 th Congress of the American Association for the Study of Liver Diseases, Washington, United States. Brazil is included in the studies and there are patients treated at the Unified Health System (SUS) receiving the drugs.

The chance of cure for patients in Brazil today is a real fact, is no longer an expectation, highlighted the infectious disease responsible for the HIV and Viral Hepatitis of the Federal University of São Paulo (Unifesp), Paul Abram.

According to the expert, will be presented at a job done with almost 2,000 patients. Of these, about 120 are Brazilians who use, between medications, telaprevir. In this work will be shown that, in the same profile of patients we treat in the SUS in Brazil, which are cirrhosis and fibrosis 3:04, the chance of cure is very high, is around 70%. This work will be displayed confirming the actions that experts working in the NHS implemented, Abram said.

The doctor explained that currently, worldwide, about 170 million people have hepatitis C. In Brazil, there are 2 million to 3 million cases. Many do not know they have the disease because there was no diagnosis. The expert added that, in Brazil, patients in serious condition receive the 130 service centers in the country, four drugs in the treatment of hepatitis. In addition to these medications that Brazil has already incorporated, others are coming that will allow the eradication of hepatitis C in the country. We are at the forefront, he said, adding that Brazil is one of the most advanced countries in terms of public health and access to medications.

Paul Abram said that the evolution of treatment walks to the incorporation of new drugs that will also be offered in Brazil. What will happen is that in the coming years these medications that are dominating the research will be incorporated in the United States and Europe, and then must come to Brazil. The future is for all developed countries and emerging economies. Hopefully in five years can cure more than 95% of patients with hepatitis C, completed.

The doctor also drew attention to the importance of the discussions that will take place at the conference in Washington on steatohepatitis, known as fatty liver disease. He explained that with the advancement of obesity in Brazil, this is a concern of specialists. As obesity in the population has been increasingly frequent, fat is also concentrated in the liver and can sometimes lead to cirrhosis patients also clarified.

According to the expert, there is still no specific drug to combat this disease, but the beginning of treatment is weight reduction. Today we know that this individual has to lose weight, do physical activity, healthy diet and may have to use some drugs being studied to reduce the level of fat in the liver. At the congress, will be presented several studies on the disease. Already have care for such patients in the NHS, although the treatment is still being studied, even in the United States and Europe there is nothing available yet, he said.

The 64 th Congress of the American Association for the Study of Liver Diseases ends on Tuesday (5).

Source: AGÊNCIA BRASIL
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Advances in the treatment of hepatitis C in Brazil will be presented in the U.S.
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Advances in the treatment of hepatitis C in Brazil will be presented in the U.S.


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
hepatitis C    American Association for the Study of Liver Diseases    Unifesp Paul Abram    health   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.